speb/financial-data huggingface dataset:
XAIR balance_sheet (annual, 2023-03-31) — Current Deferred Liabilities: 0.00
XAIR balance_sheet (annual, 2023-03-31) — Current Deferred Revenue: 0.00
XAIR balance_sheet (annual, 2023-03-31) — Current Liabilities: 19780000.00
XAIR cash_flow (annual, 2023-03-31) — Depreciation: 965000.00
XAIR cash_flow (annual, 2023-03-31) — Depreciation Amortization Depletion: 1170000.00
XAIR cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 1170000.00
XAIR balance_sheet (annual, 2023-03-31) — Derivative Product Liabilities: 0.00
XAIR income_statement (annual, 2023-03-31) — Diluted Average Shares: 74934.00
XAIR income_statement (annual, 2023-03-31) — Diluted EPS: -744.00
XAIR income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: -55816000.00
XAIR income_statement (annual, 2023-03-31) — EBIT: -59371000.00
XAIR income_statement (annual, 2023-03-31) — EBITDA: -58201000.00
XAIR cash_flow (annual, 2023-03-31) — Effect Of Exchange Rate Changes: -43000.00
XAIR cash_flow (annual, 2023-03-31) — End Cash Position: 36768000.00
XAIR cash_flow (annual, 2023-03-31) — Financing Cash Flow: 2696000.00
XAIR cash_flow (annual, 2023-03-31) — Free Cash Flow: -36886000.00
XAIR cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: 235000.00
XAIR income_statement (annual, 2023-03-31) — Gain On Sale Of Security: 551000.00
XAIR balance_sheet (annual, 2023-03-31) — Gains Losses Not Affecting Retained Earnings: 53000.00
XAIR income_statement (annual, 2023-03-31) — General And Administrative Expense: 34694000.00
XAIR balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 1632000.00
XAIR balance_sheet (annual, 2023-03-31) — Gross PPE: 8750000.00
XAIR income_statement (annual, 2023-03-31) — Gross Profit: -555000.00
XAIR cash_flow (annual, 2023-03-31) — Income Tax Paid Supplemental Data: 0.00
XAIR income_statement (annual, 2023-03-31) — Interest Expense: 30000.00
XAIR income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 30000.00
XAIR cash_flow (annual, 2023-03-31) — Interest Paid Supplemental Data: 36000.00
XAIR balance_sheet (annual, 2023-03-31) — Inventory: 1129000.00
XAIR balance_sheet (annual, 2023-03-31) — Invested Capital: 38810000.00
XAIR cash_flow (annual, 2023-03-31) — Investing Cash Flow: -20587000.00
XAIR cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 3705000.00
XAIR cash_flow (annual, 2023-03-31) — Issuance Of Debt: 0.00
XAIR balance_sheet (annual, 2023-03-31) — Leases: 581000.00
XAIR balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 2321000.00
XAIR balance_sheet (annual, 2023-03-31) — Long Term Debt: 120000.00
XAIR balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 2441000.00
XAIR cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 0.00
XAIR cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -1009000.00
XAIR balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 1284000.00
XAIR balance_sheet (annual, 2023-03-31) — Minority Interest: 4113000.00
XAIR income_statement (annual, 2023-03-31) — Minority Interests: 3585000.00
XAIR cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 3705000.00
XAIR cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: 0.00
XAIR income_statement (annual, 2023-03-31) — Net Income: -55816000.00
XAIR income_statement (annual, 2023-03-31) — Net Income Common Stockholders: -55816000.00
XAIR income_statement (annual, 2023-03-31) — Net Income Continuous Operations: -59401000.00
XAIR income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: -55816000.00
XAIR income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: -55816000.00
XAIR cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: -59401000.00
XAIR income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: -59401000.00
XAIR income_statement (annual, 2023-03-31) — Net Interest Income: -30000.00
XAIR cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: -16711000.00
XAIR cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: -1009000.00
XAIR cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: -1009000.00
XAIR income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -30000.00
XAIR cash_flow (annual, 2023-03-31) — Net Other Investing Changes: 1000.00
XAIR balance_sheet (annual, 2023-03-31) — Net PPE: 7496000.00
XAIR cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -3877000.00
XAIR cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: -1009000.00
XAIR balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 36283000.00
XAIR balance_sheet (annual, 2023-03-31) — Non Current Accrued Expenses: 4500000.00
XAIR income_statement (annual, 2023-03-31) — Normalized EBITDA: -58752000.00
XAIR income_statement (annual, 2023-03-31) — Normalized Income: -56367000.00
XAIR cash_flow (annual, 2023-03-31) — Operating Cash Flow: -33009000.00
XAIR cash_flow (annual, 2023-03-31) — Operating Gains Losses: 235000.00
XAIR income_statement (annual, 2023-03-31) — Operating Income: -52059000.00
XAIR income_statement (annual, 2023-03-31) — Operating Revenue: 0.00
XAIR balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 76846.00
XAIR balance_sheet (annual, 2023-03-31) — Other Current Assets: 338000.00
XAIR balance_sheet (annual, 2023-03-31) — Other Current Borrowings: 775000.00
XAIR balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 183000.00
XAIR balance_sheet (annual, 2023-03-31) — Other Equity Adjustments: 53000.00
XAIR income_statement (annual, 2023-03-31) — Other Gand A: 34694000.00
XAIR income_statement (annual, 2023-03-31) — Other Income Expense: -7312000.00
XAIR balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 1632000.00
XAIR cash_flow (annual, 2023-03-31) — Other Non Cash Items: -1000.00
XAIR balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 212000.00
XAIR balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: 4500000.00
XAIR income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: -7863000.00
XAIR balance_sheet (annual, 2023-03-31) — Other Properties: 6885000.00
XAIR balance_sheet (annual, 2023-03-31) — Other Receivables: 420000.00
XAIR balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 16724000.00
XAIR income_statement (annual, 2023-03-31) — Other Special Charges: 7863000.00
XAIR balance_sheet (annual, 2023-03-31) — Payables: 2016000.00
XAIR balance_sheet (annual, 2023-03-31) — Payables And Accrued Expenses: 18446000.00
XAIR balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 985000.00
XAIR balance_sheet (annual, 2023-03-31) — Preferred Stock: 0.00
XAIR balance_sheet (annual, 2023-03-31) — Prepaid Assets: 3800000.00
XAIR income_statement (annual, 2023-03-31) — Pretax Income: -59401000.00
XAIR cash_flow (annual, 2023-03-31) — Proceeds From Stock Option Exercised: 0.00
XAIR balance_sheet (annual, 2023-03-31) — Properties: 0.00
XAIR cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 49000.00
XAIR cash_flow (annual, 2023-03-31) — Purchase Of Investment: -35656000.00
XAIR cash_flow (annual, 2023-03-31) — Purchase Of PPE: -3877000.00
XAIR balance_sheet (annual, 2023-03-31) — Receivables: 651000.00
XAIR income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 555000.00
XAIR income_statement (annual, 2023-03-31) — Reconciled Depreciation: 1170000.00
XAIR cash_flow (annual, 2023-03-31) — Repayment Of Debt: -1009000.00
XAIR income_statement (annual, 2023-03-31) — Research And Development: 16810000.00
XAIR balance_sheet (annual, 2023-03-31) — Restricted Cash: 7610000.00
XAIR balance_sheet (annual, 2023-03-31) — Retained Earnings: -179455000.00
XAIR cash_flow (annual, 2023-03-31) — Sale Of Investment: 18945000.00
XAIR cash_flow (annual, 2023-03-31) — Sale Of PPE: 1000.00
XAIR income_statement (annual, 2023-03-31) — Selling General And Administration: 34694000.00
XAIR balance_sheet (annual, 2023-03-31) — Share Issued: 76846.00
XAIR cash_flow (annual, 2023-03-31) — Short Term Debt Issuance: 0.00
XAIR cash_flow (annual, 2023-03-31) — Short Term Debt Payments: -1009000.00
XAIR income_statement (annual, 2023-03-31) — Special Income Charges: 0.00
XAIR cash_flow (annual, 2023-03-31) — Stock Based Compensation: 19558000.00
XAIR balance_sheet (annual, 2023-03-31) — Stockholders Equity: 37915000.00
XAIR balance_sheet (annual, 2023-03-31) — Tangible Book Value: 36283000.00
XAIR income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 0.00
XAIR income_statement (annual, 2023-03-31) — Tax Provision: 0.00
XAIR income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.00
XAIR balance_sheet (annual, 2023-03-31) — Taxes Receivable: 231000.00
XAIR balance_sheet (annual, 2023-03-31) — Total Assets: 68749000.00
XAIR balance_sheet (annual, 2023-03-31) — Total Capitalization: 38035000.00
XAIR balance_sheet (annual, 2023-03-31) — Total Debt: 3592000.00
XAIR balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 42028000.00
XAIR income_statement (annual, 2023-03-31) — Total Expenses: 52059000.00
XAIR balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 26721000.00
XAIR balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 9340000.00
XAIR balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 6941000.00
XAIR income_statement (annual, 2023-03-31) — Total Operating Income As Reported: -52059000.00
XAIR income_statement (annual, 2023-03-31) — Total Unusual Items: 551000.00
XAIR income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 551000.00
XAIR balance_sheet (annual, 2023-03-31) — Treasury Stock: 25000.00
XAIR cash_flow (annual, 2023-03-31) — Unrealized Gain Loss On Investment Securities: -12000.00
XAIR balance_sheet (annual, 2023-03-31) — Working Capital: 39630000.00
XAIR income_statement (annual, 2024-03-31) — +Operating Expense: 61700000.00
XAIR income_statement (annual, 2024-03-31) — +Total Revenue: 1159000.00
XAIR balance_sheet (annual, 2024-03-31) — Accounts Payable: 1948000.00
XAIR balance_sheet (annual, 2024-03-31) — Accounts Receivable: 319000.00
XAIR balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -3024000.00
XAIR balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 264780000.00
XAIR cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 205000.00
XAIR cash_flow (annual, 2024-03-31) — Amortization Of Intangibles: 205000.00
XAIR cash_flow (annual, 2024-03-31) — Asset Impairment Charge: 0.00
XAIR income_statement (annual, 2024-03-31) — Basic Average Shares: 82900.00
XAIR income_statement (annual, 2024-03-31) — Basic EPS: -728.00
XAIR cash_flow (annual, 2024-03-31) — Beginning Cash Position: 36768000.00
XAIR cash_flow (annual, 2024-03-31) — Capital Expenditure: -5745000.00
XAIR balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 2316000.00
XAIR balance_sheet (annual, 2024-03-31) — Capital Stock: 5000.00
XAIR balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 11378000.00
XAIR balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 34468000.00
XAIR cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Financing Activities: 43167000.00
XAIR cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Investing Activities: -12235000.00
XAIR cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Operating Activities: -56015000.00
XAIR cash_flow (annual, 2024-03-31) — Change In Account Payable: -467000.00
XAIR cash_flow (annual, 2024-03-31) — Change In Accrued Expense: -12710000.00
XAIR cash_flow (annual, 2024-03-31) — Change In Inventory: -998000.00
XAIR cash_flow (annual, 2024-03-31) — Change In Other Current Assets: -1583000.00
XAIR cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: -381000.00
XAIR cash_flow (annual, 2024-03-31) — Change In Payable: -467000.00
XAIR cash_flow (annual, 2024-03-31) — Change In Payables And Accrued Expense: -13177000.00
XAIR cash_flow (annual, 2024-03-31) — Change In Receivables: 101000.00
XAIR cash_flow (annual, 2024-03-31) — Change In Working Capital: -16038000.00
XAIR cash_flow (annual, 2024-03-31) — Changes In Account Receivables: -319000.00
XAIR cash_flow (annual, 2024-03-31) — Changes In Cash: -25083000.00
XAIR balance_sheet (annual, 2024-03-31) — Common Stock: 5000.00
XAIR balance_sheet (annual, 2024-03-31) — Common Stock Equity: 25048000.00
XAIR cash_flow (annual, 2024-03-31) — Common Stock Issuance: 27967000.00
XAIR income_statement (annual, 2024-03-31) — Cost Of Revenue: 2466000.00
XAIR balance_sheet (annual, 2024-03-31) — Current Accrued Expenses: 7989000.00
XAIR balance_sheet (annual, 2024-03-31) — Current Assets: 43936000.00
XAIR balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 418000.00
XAIR balance_sheet (annual, 2024-03-31) — Current Debt: 800000.00
XAIR balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 1218000.00
XAIR balance_sheet (annual, 2024-03-31) — Current Deferred Liabilities: 138000.00
XAIR balance_sheet (annual, 2024-03-31) — Current Deferred Revenue: 138000.00
XAIR balance_sheet (annual, 2024-03-31) — Current Liabilities: 11567000.00
XAIR cash_flow (annual, 2024-03-31) — Depreciation: 2147000.00
XAIR cash_flow (annual, 2024-03-31) — Depreciation Amortization Depletion: 2352000.00
XAIR cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 2352000.00
XAIR balance_sheet (annual, 2024-03-31) — Derivative Product Liabilities: 1589000.00
XAIR income_statement (annual, 2024-03-31) — Diluted Average Shares: 82900.00
XAIR income_statement (annual, 2024-03-31) — Diluted EPS: -728.00
XAIR income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: -60242000.00
XAIR income_statement (annual, 2024-03-31) — EBIT: -61383000.00
XAIR income_statement (annual, 2024-03-31) — EBITDA: -59031000.00
XAIR cash_flow (annual, 2024-03-31) — Effect Of Exchange Rate Changes: -77000.00
XAIR cash_flow (annual, 2024-03-31) — End Cash Position: 11608000.00
XAIR cash_flow (annual, 2024-03-31) — Financing Cash Flow: 43167000.00
XAIR cash_flow (annual, 2024-03-31) — Free Cash Flow: -61759000.00
XAIR cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -659000.00
XAIR cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: 15000.00
XAIR income_statement (annual, 2024-03-31) — Gain On Sale Of Ppe: 0.00
XAIR income_statement (annual, 2024-03-31) — Gain On Sale Of Security: 2392000.00
XAIR balance_sheet (annual, 2024-03-31) — Gains Losses Not Affecting Retained Earnings: -15000.00
XAIR income_statement (annual, 2024-03-31) — General And Administrative Expense: 37337000.00
XAIR balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 1427000.00
XAIR balance_sheet (annual, 2024-03-31) — Gross PPE: 14509000.00
XAIR income_statement (annual, 2024-03-31) — Gross Profit: -1307000.00
XAIR cash_flow (annual, 2024-03-31) — Income Tax Paid Supplemental Data: 0.00
XAIR income_statement (annual, 2024-03-31) — Interest Expense: 2912000.00
XAIR income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 2912000.00
XAIR cash_flow (annual, 2024-03-31) — Interest Paid Supplemental Data: 1759000.00
XAIR balance_sheet (annual, 2024-03-31) — Inventory: 2127000.00
XAIR balance_sheet (annual, 2024-03-31) — Invested Capital: 40569000.00
XAIR cash_flow (annual, 2024-03-31) — Investing Cash Flow: -12235000.00
XAIR cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 27967000.00
XAIR cash_flow (annual, 2024-03-31) — Issuance Of Debt: 15818000.00
XAIR balance_sheet (annual, 2024-03-31) — Leases: 612000.00
XAIR balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 1898000.00
XAIR balance_sheet (annual, 2024-03-31) — Long Term Debt: 14721000.00
XAIR balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 16619000.00
XAIR cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 15818000.00
XAIR cash_flow (annual, 2024-03-31) — Long Term Debt Payments: -835000.00
XAIR balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 1394000.00
XAIR balance_sheet (annual, 2024-03-31) — Minority Interest: 2138000.00
XAIR income_statement (annual, 2024-03-31) — Minority Interests: 4053000.00
XAIR cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 27967000.00
XAIR balance_sheet (annual, 2024-03-31) — Net Debt: 4143000.00
XAIR income_statement (annual, 2024-03-31) — Net Income: -60242000.00
XAIR income_statement (annual, 2024-03-31) — Net Income Common Stockholders: -60242000.00
XAIR income_statement (annual, 2024-03-31) — Net Income Continuous Operations: -64295000.00
XAIR income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: -60242000.00
XAIR income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: -60242000.00
XAIR cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: -64295000.00
XAIR income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: -64295000.00
XAIR income_statement (annual, 2024-03-31) — Net Interest Income: -2912000.00
XAIR cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: -6490000.00
XAIR cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: 14983000.00
XAIR cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: 14983000.00
XAIR income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -2912000.00
XAIR balance_sheet (annual, 2024-03-31) — Net PPE: 11485000.00
XAIR cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -5745000.00
XAIR balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 23621000.00
XAIR income_statement (annual, 2024-03-31) — Normalized EBITDA: -61423000.00
XAIR income_statement (annual, 2024-03-31) — Normalized Income: -62634000.00
XAIR cash_flow (annual, 2024-03-31) — Operating Cash Flow: -56014000.00
XAIR cash_flow (annual, 2024-03-31) — Operating Gains Losses: -644000.00
XAIR income_statement (annual, 2024-03-31) — Operating Income: -63007000.00
XAIR income_statement (annual, 2024-03-31) — Operating Revenue: 1159000.00
XAIR balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 114752.00
XAIR balance_sheet (annual, 2024-03-31) — Other Current Assets: 277000.00
XAIR balance_sheet (annual, 2024-03-31) — Other Current Borrowings: 800000.00
XAIR balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 274000.00
XAIR balance_sheet (annual, 2024-03-31) — Other Equity Adjustments: -15000.00
XAIR income_statement (annual, 2024-03-31) — Other Gand A: 37337000.00
XAIR income_statement (annual, 2024-03-31) — Other Income Expense: 1625000.00
XAIR balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 1427000.00
XAIR cash_flow (annual, 2024-03-31) — Other Non Cash Items: 1151000.00
XAIR balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 113000.00
XAIR income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: -767000.00
XAIR balance_sheet (annual, 2024-03-31) — Other Properties: 12503000.00
XAIR balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 23090000.00
XAIR income_statement (annual, 2024-03-31) — Other Special Charges: 598000.00
XAIR balance_sheet (annual, 2024-03-31) — Payables: 1948000.00
XAIR balance_sheet (annual, 2024-03-31) — Payables And Accrued Expenses: 9937000.00
XAIR balance_sheet (annual, 2024-03-31) — Preferred Stock: 0.00
XAIR balance_sheet (annual, 2024-03-31) — Prepaid Assets: 6286000.00
XAIR income_statement (annual, 2024-03-31) — Pretax Income: -64295000.00
XAIR cash_flow (annual, 2024-03-31) — Proceeds From Stock Option Exercised: 217000.00
XAIR balance_sheet (annual, 2024-03-31) — Properties: 0.00
XAIR cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: 0.00
XAIR cash_flow (annual, 2024-03-31) — Purchase Of Investment: -128770000.00
XAIR cash_flow (annual, 2024-03-31) — Purchase Of PPE: -5745000.00
XAIR balance_sheet (annual, 2024-03-31) — Receivables: 548000.00
XAIR income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 2466000.00
XAIR income_statement (annual, 2024-03-31) — Reconciled Depreciation: 2352000.00
XAIR cash_flow (annual, 2024-03-31) — Repayment Of Debt: -835000.00
XAIR income_statement (annual, 2024-03-31) — Research And Development: 24363000.00
XAIR balance_sheet (annual, 2024-03-31) — Restricted Cash: 230000.00
XAIR balance_sheet (annual, 2024-03-31) — Retained Earnings: -239697000.00
XAIR cash_flow (annual, 2024-03-31) — Sale Of Investment: 122280000.00
XAIR income_statement (annual, 2024-03-31) — Selling General And Administration: 37337000.00
XAIR balance_sheet (annual, 2024-03-31) — Share Issued: 114752.00
XAIR income_statement (annual, 2024-03-31) — Special Income Charges: 0.00
XAIR cash_flow (annual, 2024-03-31) — Stock Based Compensation: 21337000.00
XAIR balance_sheet (annual, 2024-03-31) — Stockholders Equity: 25048000.00
XAIR balance_sheet (annual, 2024-03-31) — Tangible Book Value: 23621000.00
XAIR income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 0.00
XAIR income_statement (annual, 2024-03-31) — Tax Provision: 0.00
XAIR income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.00
XAIR balance_sheet (annual, 2024-03-31) — Taxes Receivable: 229000.00
XAIR balance_sheet (annual, 2024-03-31) — Total Assets: 56961000.00
XAIR balance_sheet (annual, 2024-03-31) — Total Capitalization: 39769000.00
XAIR balance_sheet (annual, 2024-03-31) — Total Debt: 17837000.00
XAIR balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 27186000.00
XAIR income_statement (annual, 2024-03-31) — Total Expenses: 64166000.00
XAIR balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 29775000.00
XAIR balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 13025000.00
XAIR balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 18208000.00
XAIR income_statement (annual, 2024-03-31) — Total Operating Income As Reported: -63006000.00
XAIR income_statement (annual, 2024-03-31) — Total Unusual Items: 2392000.00
XAIR income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 2392000.00
XAIR balance_sheet (annual, 2024-03-31) — Treasury Stock: 25000.00
XAIR cash_flow (annual, 2024-03-31) — Unrealized Gain Loss On Investment Securities: 123000.00
XAIR balance_sheet (annual, 2024-03-31) — Working Capital: 32369000.00
XAIR cash_flow (quarterly, 2024-09-30) — Change In Account Payable: -1008000.00
XAIR balance_sheet (quarterly, 2024-09-30) — Current Debt: 258000.00
XAIR cash_flow (quarterly, 2024-09-30) — Gain Loss On Sale Of PPE: 220000.00
XAIR balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 10940000.00
XAIR cash_flow (quarterly, 2024-09-30) — Net Foreign Currency Exchange Gain Loss: 0.00
XAIR balance_sheet (quarterly, 2024-09-30) — Other Current Borrowings: 258000.00
XAIR balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: 4427000.00
XAIR balance_sheet (quarterly, 2024-09-30) — Other Receivables: 370000.00
XAIR income_statement (quarterly, 2024-09-30) — Other Special Charges: 624000.00
XAIR income_statement (quarterly, 2024-12-31) — +Operating Expense: 10737000.00
XAIR income_statement (quarterly, 2024-12-31) — +Total Revenue: 1072000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 2357000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 639000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -5089000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 296000000.00
XAIR cash_flow (quarterly, 2024-12-31) — Amortization Cash Flow: 52000.00
XAIR cash_flow (quarterly, 2024-12-31) — Amortization Of Intangibles: 52000.00
XAIR cash_flow (quarterly, 2024-12-31) — Asset Impairment Charge: 163000.00
XAIR income_statement (quarterly, 2024-12-31) — Basic Average Shares: 4403725.00
XAIR income_statement (quarterly, 2024-12-31) — Basic EPS: -3.00
XAIR cash_flow (quarterly, 2024-12-31) — Beginning Cash Position: 28677000.00
XAIR cash_flow (quarterly, 2024-12-31) — Capital Expenditure: -537000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 1948000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Capital Stock: 7000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 4601000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 10950000.00
XAIR cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Financing Activities: -9214000.00
XAIR cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Investing Activities: -6938000.00
XAIR cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Operating Activities: -7732000.00
XAIR cash_flow (quarterly, 2024-12-31) — Change In Account Payable: 831000.00
XAIR cash_flow (quarterly, 2024-12-31) — Change In Accrued Expense: -1880000.00
XAIR cash_flow (quarterly, 2024-12-31) — Change In Inventory: 140000.00
XAIR cash_flow (quarterly, 2024-12-31) — Change In Other Current Assets: 1133000.00
XAIR cash_flow (quarterly, 2024-12-31) — Change In Other Current Liabilities: -73000.00
XAIR cash_flow (quarterly, 2024-12-31) — Change In Payable: 831000.00
XAIR cash_flow (quarterly, 2024-12-31) — Change In Payables And Accrued Expense: -1049000.00
XAIR cash_flow (quarterly, 2024-12-31) — Change In Receivables: -83000.00
XAIR cash_flow (quarterly, 2024-12-31) — Change In Working Capital: 68000.00
XAIR cash_flow (quarterly, 2024-12-31) — Changes In Account Receivables: -83000.00
XAIR cash_flow (quarterly, 2024-12-31) — Changes In Cash: -23883000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Common Stock: 7000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 17643000.00
XAIR cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 0.00
XAIR income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 1287000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Current Accrued Expenses: 2320000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Current Assets: 19344000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 381000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Current Debt: 60000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 441000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Current Deferred Liabilities: 0.00
XAIR balance_sheet (quarterly, 2024-12-31) — Current Deferred Revenue: 0.00
XAIR balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 5430000.00
XAIR cash_flow (quarterly, 2024-12-31) — Depreciation: 804000.00
XAIR cash_flow (quarterly, 2024-12-31) — Depreciation Amortization Depletion: 856000.00
XAIR cash_flow (quarterly, 2024-12-31) — Depreciation And Amortization: 856000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Derivative Product Liabilities: 56000.00
XAIR income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 4403725.00
XAIR income_statement (quarterly, 2024-12-31) — Diluted EPS: -3.00
XAIR income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: -13032000.00
XAIR income_statement (quarterly, 2024-12-31) — EBIT: -12784000.00
XAIR income_statement (quarterly, 2024-12-31) — EBITDA: -11928000.00
XAIR cash_flow (quarterly, 2024-12-31) — Effect Of Exchange Rate Changes: 39000.00
XAIR cash_flow (quarterly, 2024-12-31) — End Cash Position: 4833000.00
XAIR cash_flow (quarterly, 2024-12-31) — Financing Cash Flow: -9214000.00
XAIR cash_flow (quarterly, 2024-12-31) — Free Cash Flow: -8270000.00
XAIR cash_flow (quarterly, 2024-12-31) — Gain Loss On Investment Securities: -5000.00
XAIR income_statement (quarterly, 2024-12-31) — Gain On Sale Of Ppe: -62000.00
XAIR income_statement (quarterly, 2024-12-31) — Gain On Sale Of Security: 176000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -51000.00
XAIR income_statement (quarterly, 2024-12-31) — General And Administrative Expense: 7732000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Goodwill And Other Intangible Assets: 1274000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Gross PPE: 18517000.00
XAIR income_statement (quarterly, 2024-12-31) — Gross Profit: -215000.00
XAIR cash_flow (quarterly, 2024-12-31) — Income Tax Paid Supplemental Data: 0.00
XAIR income_statement (quarterly, 2024-12-31) — Interest Expense: 549000.00
XAIR income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 549000.00
XAIR cash_flow (quarterly, 2024-12-31) — Interest Paid Supplemental Data: 2000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Interest Payable: 98000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Inventory: 2379000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Invested Capital: 17703000.00
XAIR cash_flow (quarterly, 2024-12-31) — Investing Cash Flow: -6937000.00
XAIR cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 0.00
XAIR cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 3824000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Leases: 509000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 1567000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 1567000.00
XAIR cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: 3824000.00
XAIR cash_flow (quarterly, 2024-12-31) — Long Term Debt Payments: -12952000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 1432000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Minority Interest: 738000.00
XAIR income_statement (quarterly, 2024-12-31) — Minority Interests: 300000.00
XAIR cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 0.00
XAIR cash_flow (quarterly, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: 0.00
XAIR income_statement (quarterly, 2024-12-31) — Net Income: -13032000.00
XAIR income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: -13032000.00
XAIR income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: -13333000.00
XAIR income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -13032000.00
XAIR income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -13032000.00
XAIR cash_flow (quarterly, 2024-12-31) — Net Income From Continuing Operations: -13333000.00
XAIR income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: -13333000.00
XAIR income_statement (quarterly, 2024-12-31) — Net Interest Income: -549000.00
XAIR cash_flow (quarterly, 2024-12-31) — Net Investment Purchase And Sale: -6401000.00
XAIR cash_flow (quarterly, 2024-12-31) — Net Issuance Payments Of Debt: -9128000.00
XAIR cash_flow (quarterly, 2024-12-31) — Net Long Term Debt Issuance: -9128000.00
XAIR income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -549000.00
XAIR cash_flow (quarterly, 2024-12-31) — Net Other Investing Changes: 1000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Net PPE: 13428000.00
XAIR cash_flow (quarterly, 2024-12-31) — Net PPE Purchase And Sale: -537000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: 16369000.00
XAIR income_statement (quarterly, 2024-12-31) — Normalized EBITDA: -10132000.00
XAIR income_statement (quarterly, 2024-12-31) — Normalized Income: -11236000.00
XAIR cash_flow (quarterly, 2024-12-31) — Operating Cash Flow: -7733000.00
XAIR cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: 1685000.00
XAIR income_statement (quarterly, 2024-12-31) — Operating Income: -10952000.00
XAIR income_statement (quarterly, 2024-12-31) — Operating Revenue: 1072000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 3716432.00
XAIR balance_sheet (quarterly, 2024-12-31) — Other Current Assets: 183000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Other Current Borrowings: 60000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 312000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Other Equity Adjustments: -51000.00
XAIR income_statement (quarterly, 2024-12-31) — Other Gand A: 7732000.00
XAIR income_statement (quarterly, 2024-12-31) — Other Income Expense: -1833000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 1274000.00
XAIR cash_flow (quarterly, 2024-12-31) — Other Non Cash Items: 118000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Other Non Current Assets: 100000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Other Non Current Liabilities: 8710000.00
XAIR income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: -37000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Other Properties: 16576000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Other Short Term Investments: 6349000.00
XAIR income_statement (quarterly, 2024-12-31) — Other Special Charges: 1910000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Payables: 2357000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Payables And Accrued Expenses: 4677000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Preferred Stock: 0.00
XAIR balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 4876000.00
XAIR income_statement (quarterly, 2024-12-31) — Pretax Income: -13333000.00
XAIR cash_flow (quarterly, 2024-12-31) — Proceeds From Stock Option Exercised: -86000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
XAIR cash_flow (quarterly, 2024-12-31) — Provisionand Write Offof Assets: 8000.00
XAIR cash_flow (quarterly, 2024-12-31) — Purchase Of Investment: -12397000.00
XAIR cash_flow (quarterly, 2024-12-31) — Purchase Of PPE: -537000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Receivables: 724000.00
XAIR income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 1287000.00
XAIR income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 856000.00
XAIR cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: -12952000.00
XAIR income_statement (quarterly, 2024-12-31) — Research And Development: 3005000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Restricted Cash: 232000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -278288000.00
XAIR cash_flow (quarterly, 2024-12-31) — Sale Of Investment: 5996000.00
XAIR income_statement (quarterly, 2024-12-31) — Selling General And Administration: 7732000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Share Issued: 3716432.00
XAIR income_statement (quarterly, 2024-12-31) — Special Income Charges: -1972000.00
XAIR cash_flow (quarterly, 2024-12-31) — Stock Based Compensation: 2480000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 17643000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 16369000.00
XAIR income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
XAIR income_statement (quarterly, 2024-12-31) — Tax Provision: 0.00
XAIR income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.00
XAIR balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 85000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Total Assets: 34144000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 17643000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Total Debt: 2008000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 18381000.00
XAIR income_statement (quarterly, 2024-12-31) — Total Expenses: 12024000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 15763000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 14802000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 10333000.00
XAIR income_statement (quarterly, 2024-12-31) — Total Operating Income As Reported: -10952000.00
XAIR income_statement (quarterly, 2024-12-31) — Total Unusual Items: -1796000.00
XAIR income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: -1796000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Treasury Stock: 25000.00
XAIR cash_flow (quarterly, 2024-12-31) — Unrealized Gain Loss On Investment Securities: 51000.00
XAIR balance_sheet (quarterly, 2024-12-31) — Working Capital: 13914000.00
XAIR income_statement (annual, 2025-03-31) — +Operating Expense: 42874000.00
XAIR income_statement (quarterly, 2025-03-31) — +Operating Expense: 7142000.00
XAIR income_statement (annual, 2025-03-31) — +Total Revenue: 3705000.00
XAIR income_statement (quarterly, 2025-03-31) — +Total Revenue: 1152000.00
XAIR balance_sheet (annual, 2025-03-31) — Accounts Payable: 1950000.00
XAIR balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 1950000.00
XAIR balance_sheet (annual, 2025-03-31) — Accounts Receivable: 710000.00
XAIR balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 710000.00
XAIR balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -5500000.00
XAIR balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -5500000.00
XAIR balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 299990000.00
XAIR balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 299990000.00
XAIR cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 205000.00
XAIR cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 51000.00
XAIR cash_flow (annual, 2025-03-31) — Amortization Of Intangibles: 205000.00
XAIR cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: 51000.00
XAIR cash_flow (annual, 2025-03-31) — Asset Impairment Charge: 505000.00
XAIR cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 171000.00
XAIR income_statement (annual, 2025-03-31) — Basic Average Shares: 169266.00
XAIR income_statement (quarterly, 2025-03-31) — Basic Average Shares: 224948.00
XAIR income_statement (annual, 2025-03-31) — Basic EPS: -276.00
XAIR income_statement (quarterly, 2025-03-31) — Basic EPS: -36.00
XAIR cash_flow (annual, 2025-03-31) — Beginning Cash Position: 11608000.00
XAIR cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 4833000.00
XAIR cash_flow (annual, 2025-03-31) — Capital Expenditure: -5883000.00
XAIR cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -1498000.00
XAIR balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 1882000.00
XAIR balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 1882000.00
XAIR balance_sheet (annual, 2025-03-31) — Capital Stock: 0.00
XAIR balance_sheet (quarterly, 2025-03-31) — Capital Stock: 0.00
XAIR balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 4665000.00
XAIR balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 4665000.00
XAIR balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 6917000.00
XAIR balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 6917000.00
XAIR cash_flow (annual, 2025-03-31) — Cash Flow From Continuing Financing Activities: 16646000.00
XAIR cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 4500000.00
XAIR cash_flow (annual, 2025-03-31) — Cash Flow From Continuing Investing Activities: 14905000.00
XAIR cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 2581000.00
XAIR cash_flow (annual, 2025-03-31) — Cash Flow From Continuing Operating Activities: -38218000.00
XAIR cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -6957000.00
XAIR cash_flow (annual, 2025-03-31) — Change In Account Payable: 399000.00
XAIR cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 85000.00
XAIR cash_flow (annual, 2025-03-31) — Change In Accrued Expense: -6358000.00
XAIR cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -546000.00
XAIR cash_flow (annual, 2025-03-31) — Change In Inventory: -466000.00
XAIR cash_flow (quarterly, 2025-03-31) — Change In Inventory: 126000.00
XAIR cash_flow (annual, 2025-03-31) — Change In Other Current Assets: 1048000.00
XAIR cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: -601000.00
XAIR cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: -385000.00
XAIR cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -66000.00
XAIR cash_flow (annual, 2025-03-31) — Change In Payable: 399000.00
XAIR cash_flow (quarterly, 2025-03-31) — Change In Payable: 85000.00
XAIR cash_flow (annual, 2025-03-31) — Change In Payables And Accrued Expense: -5959000.00
XAIR cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -461000.00
XAIR cash_flow (annual, 2025-03-31) — Change In Receivables: -390000.00
XAIR cash_flow (quarterly, 2025-03-31) — Change In Receivables: -70000.00
XAIR cash_flow (annual, 2025-03-31) — Change In Working Capital: -6152000.00
XAIR cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -1072000.00
XAIR cash_flow (annual, 2025-03-31) — Changes In Account Receivables: -390000.00
XAIR cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -70000.00
XAIR cash_flow (annual, 2025-03-31) — Changes In Cash: -6667000.00
XAIR cash_flow (quarterly, 2025-03-31) — Changes In Cash: 124000.00
XAIR balance_sheet (annual, 2025-03-31) — Common Stock: 0.00
XAIR balance_sheet (quarterly, 2025-03-31) — Common Stock: 0.00
XAIR balance_sheet (annual, 2025-03-31) — Common Stock Equity: 13583000.00
XAIR balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 13583000.00
XAIR cash_flow (annual, 2025-03-31) — Common Stock Issuance: 23009000.00
XAIR cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 3509000.00
XAIR income_statement (annual, 2025-03-31) — Cost Of Revenue: 5368000.00
XAIR income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 1184000.00
XAIR balance_sheet (annual, 2025-03-31) — Current Accrued Expenses: 1822000.00
XAIR balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 1822000.00
XAIR balance_sheet (annual, 2025-03-31) — Current Assets: 16018000.00
XAIR balance_sheet (quarterly, 2025-03-31) — Current Assets: 16018000.00
XAIR balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 396000.00
XAIR balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 396000.00
XAIR balance_sheet (annual, 2025-03-31) — Current Debt: 609000.00
XAIR balance_sheet (quarterly, 2025-03-31) — Current Debt: 609000.00
XAIR balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 1005000.00
XAIR balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 1005000.00
XAIR balance_sheet (annual, 2025-03-31) — Current Deferred Liabilities: 0.00
XAIR balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 0.00
XAIR balance_sheet (annual, 2025-03-31) — Current Deferred Revenue: 0.00
XAIR balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 0.00
XAIR balance_sheet (annual, 2025-03-31) — Current Liabilities: 5000000.00
XAIR balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 5000000.00
XAIR cash_flow (annual, 2025-03-31) — Depreciation: 3366000.00
XAIR cash_flow (quarterly, 2025-03-31) — Depreciation: 888000.00
XAIR cash_flow (annual, 2025-03-31) — Depreciation Amortization Depletion: 3571000.00
XAIR cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 939000.00
XAIR cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 3571000.00
XAIR cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 939000.00
XAIR balance_sheet (annual, 2025-03-31) — Derivative Product Liabilities: 38000.00
XAIR balance_sheet (quarterly, 2025-03-31) — Derivative Product Liabilities: 38000.00
XAIR income_statement (annual, 2025-03-31) — Diluted Average Shares: 169266.00
XAIR income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 224948.00
XAIR income_statement (annual, 2025-03-31) — Diluted EPS: -276.00
XAIR income_statement (quarterly, 2025-03-31) — Diluted EPS: -36.00
XAIR income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: -46625000.00
XAIR income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -8034000.00
XAIR income_statement (annual, 2025-03-31) — EBIT: -45460000.00
XAIR income_statement (quarterly, 2025-03-31) — EBIT: -7483000.00
XAIR income_statement (annual, 2025-03-31) — EBITDA: -41889000.00
XAIR income_statement (quarterly, 2025-03-31) — EBITDA: -6544000.00
XAIR cash_flow (annual, 2025-03-31) — Effect Of Exchange Rate Changes: -45000.00
XAIR cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: -61000.00
XAIR cash_flow (annual, 2025-03-31) — End Cash Position: 4896000.00
XAIR cash_flow (quarterly, 2025-03-31) — End Cash Position: 4896000.00
XAIR cash_flow (annual, 2025-03-31) — Financing Cash Flow: 16646000.00
XAIR cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 4500000.00
XAIR cash_flow (annual, 2025-03-31) — Free Cash Flow: -44101000.00
XAIR cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -8455000.00
XAIR cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: -1551000.00
XAIR cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: -18000.00
XAIR cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: 334000.00
XAIR income_statement (annual, 2025-03-31) — Gain On Sale Of Ppe: -738000.00
XAIR income_statement (quarterly, 2025-03-31) — Gain On Sale Of Ppe: -505000.00
XAIR income_statement (annual, 2025-03-31) — Gain On Sale Of Security: 2253000.00
XAIR income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 109000.00
XAIR balance_sheet (annual, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -60000.00
XAIR balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -60000.00
XAIR income_statement (annual, 2025-03-31) — General And Administrative Expense: 26017000.00
XAIR income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 3884000.00
XAIR balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 1222000.00
XAIR balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 1222000.00
XAIR balance_sheet (annual, 2025-03-31) — Gross PPE: 18219000.00
XAIR balance_sheet (quarterly, 2025-03-31) — Gross PPE: 18219000.00
XAIR income_statement (annual, 2025-03-31) — Gross Profit: -1663000.00
XAIR income_statement (quarterly, 2025-03-31) — Gross Profit: -32000.00
XAIR cash_flow (annual, 2025-03-31) — Income Tax Paid Supplemental Data: 0.00
XAIR cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 0.00
XAIR income_statement (annual, 2025-03-31) — Interest Expense: 3019000.00
XAIR income_statement (quarterly, 2025-03-31) — Interest Expense: 580000.00
XAIR income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 3019000.00
XAIR income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 580000.00
XAIR cash_flow (annual, 2025-03-31) — Interest Paid Supplemental Data: 1197000.00
XAIR cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 85000.00
XAIR balance_sheet (annual, 2025-03-31) — Interest Payable: 0.00
XAIR balance_sheet (quarterly, 2025-03-31) — Interest Payable: 0.00
XAIR balance_sheet (annual, 2025-03-31) — Inventory: 2417000.00
XAIR balance_sheet (quarterly, 2025-03-31) — Inventory: 2417000.00
XAIR balance_sheet (annual, 2025-03-31) — Invested Capital: 23389000.00
XAIR balance_sheet (quarterly, 2025-03-31) — Invested Capital: 23389000.00
XAIR cash_flow (annual, 2025-03-31) — Investing Cash Flow: 14905000.00
XAIR cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 2581000.00
XAIR cash_flow (annual, 2025-03-31) — Issuance Of Capital Stock: 23009000.00
XAIR cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 3509000.00
XAIR cash_flow (annual, 2025-03-31) — Issuance Of Debt: 11324000.00
XAIR cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 0.00
XAIR balance_sheet (annual, 2025-03-31) — Leases: 521000.00
XAIR balance_sheet (quarterly, 2025-03-31) — Leases: 521000.00
XAIR balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 1486000.00
XAIR balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 1486000.00
XAIR balance_sheet (annual, 2025-03-31) — Long Term Debt: 9197000.00
XAIR balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 9197000.00
XAIR balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 10683000.00
XAIR balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 10683000.00
XAIR cash_flow (annual, 2025-03-31) — Long Term Debt Issuance: 11324000.00
XAIR cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 0.00
XAIR cash_flow (annual, 2025-03-31) — Long Term Debt Payments: -18052000.00